C77.0
Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck
Clinical Classification Guidelines
Inclusion Terms
- Secondary and unspecified malignant neoplasm of supraclavicular lymph nodes
Medical Intelligence & Overview
ICD-10 code C77.0 refers to secondary and unspecified malignant tumors found in the lymph nodes located in the head, face, and neck regions. These lymph nodes are part of the body's immune system and are important in fighting infections. When a malignant tumor develops in these nodes, it can be a sign of cancer that has spread from another part of the body or an unidentified primary source. This condition often requires comprehensive medical evaluation to determine the origin and appropriate treatment approach.
Causes & Symptoms
Clinical Causes: Spread of cancer from primary tumors located in other parts of the body, such as the head, face, or neck Secondary involvement from distant cancers that metastasize to regional lymph nodes Unspecified or unknown primary cancer with metastasis to lymph nodes
Key Symptoms: Swelling or lumps in the neck, face, or head areas Persistent pain or discomfort in the affected regions Difficulty swallowing or a sensation of something stuck in the throat Unexplained weight loss Fatigue or general feelings of being unwell Possible skin changes or ulcerations over the affected lymph nodes
Diagnostic & Treatment
Diagnosis Path: Diagnosing secondary malignant lymph node involvement involves a combination of medical examinations and tests. These may include:
Treatment Protocols: Treatment strategies for secondary malignant neoplasms of lymph nodes depend on the origin and spread of cancer, as well as the patient's overall health. Common approaches include:
Clinical Advice & FAQs
Billing Guidance
Is C77.0 a billable ICD-10 code?
Yes, C77.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C77.0?
Clinical documentation must specify the nature of Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck and any associated comorbidities for accurate reporting.
Cite this Clinical Reference